Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10453718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety.

  1997cited by this paper
• Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

  1997cited by this paper
• Interactions of lactone, carboxylate and self‐aggregated forms of camptothecin with human and bovine serum albumins

  1997cited by this paper
• Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol.

  1997cited by this paper
• Protocols for the Treatment of Human Tumor Xenografts with Camptothecins

  1996cited by this paper
• Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity.

  1996cited by this paper
• Current perspectives on camptothecins in cancer treatment.

  1996cited by this paper
• Phase I Clinical and Pharmacological Studies of 20‐(S)‐Camptothecin and 20‐(S)‐9‐Nitrocamptothecin as Anticancer Agents

  1996cited by this paper
• Antitumor effect of liposome‐incorporated camptothecin in human malignant xenografts

  1995cited by this paper
• Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.

  1995cited by this paper
• Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.

  1995cited by this paper
• Partial characterization of human leukemia U‐937 cell sublines resistant to 9‐nitrocamptothecin P

  1994cited by this paper
• Pharmacokinetics of the in vivo and in vitro conversion of 9-nitro-20(S)-camptothecin to 9-amino-20(S)-camptothecin in humans, dogs, and mice.

  1994cited by this paper
• Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice

  1994cited by this paper
• Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells in vitro

  1993cited by this paper
• Preferential binding of the carboxylate form of camptothecin by human serum albumin.

  1993cited by this paper
• Lipid bilayer partitioning and stability of camptothecin drugs.

  1993cited by this paper
• Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts.

  1993cited by this paper
• Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice

  1992cited by this paper
• Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.

  1991cited by this paper
• Antiviral therapy with small particle aerosols

  1988cited by this paper
• Estimating the dosage of ribavirin aerosol according to age and other variables.

  1988cited by this paper
• Measurement of respiratory volume for virus retention studies in mice.

  1972cited by this paper
• Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells.

  1972cited by this paper

• Pulmonary delivery of anti-infectives from natural sources: Development and characterization of liposomal sanggenon formulations.

  2025cites this paper
• Liposomal Nanoformulation-encapsulated Paclitaxel for Reducing Chemotherapy Side Effects in Lung Cancer Treatments: Recent Advances and Future Outlooks.

  2024cites this paper
• Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: previous strategies, recent advances and key factors description.

  2023cites this paper
• Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer

  2022cites this paper
• Recent Advances in the Local Drug Delivery Systems for Improvement of Anticancer Therapy.

  2021cites this paper
• Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis

  2020cites this paper
• An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases

  2019cites this paper
• Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluation.

  2018cites this paper
• Synthesis of polyphosphazene and preparation of microspheres from polyphosphazene blends with PMMA for drug combination therapy

  2018cites this paper
• The potential to treat lung cancer via inhalation of repurposed drugs.

  2018cites this paper
• Loco-regional administration of nanomedicines for the treatment of lung cancer

  2016cites this paper
• Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.

  2016cites this paper
• Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications

  2016cites this paper
• Liposomal delivery systems for anti-cancer analogues of vitamin E.

  2015cites this paper
• Cancer Nanotechnology Plan 2015

  2015cites this paper
• Aerosol Delivery in the Treatment of Lung Cancer.

  2015cites this paper
• Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma

  2015cites this paper
• Lipid-based carriers for pulmonary products: preclinical development and case studies in humans.

  2014cites this paper
• Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis

  2014cites this paper
• Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.

  2014cites this paper
• Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.

  2013cites this paper
• A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

  2013cites this paper
• Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer.

  2013cites this paper
• Liposomal formulations for inhalation.

  2013cites this paper
• Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.

  2013cites this paper
• Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

  2012cites this paper
• Inhaled chemotherapy in lung cancer: future concept of nanomedicine

  2012cites this paper
• Pharmacokinetics and disposition of various drug loaded liposomes.

  2012cites this paper
• Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies

  2011cites this paper
• The Airways: A Promising Route for the Pulmonary Delivery of Anticancer Agents

  2011cites this paper
• Alternatives to conventional suspensions for pulmonary drug delivery by nebulisers: a review.

  2011cites this paper
• Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model

  2010cites this paper
• Development of a highly stable and targetable nanoliposomal formulation of topotecan.

  2010cites this paper
• In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy.

  2010influential citation
• Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery.

  2010cites this paper
• Pulmonary Formulations: What Remains to be Done?

  2010cites this paper
• The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.

  2010cites this paper
• Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary Tumor Burden and Metastases

  2009cites this paper
• Tumor Burden and Metastases Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary

  2009cites this paper
• The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

  2009cites this paper
• Liposomal Encapsulation of Deguelin: Evidence for Enhanced Antitumor Activity in Tobacco Carcinogen–Induced and Oncogenic K-ras–Induced Lung Tumorigenesis

  2009cites this paper
• Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.

  2009cites this paper
• Preparation of Large Monodisperse Vesicles

  2009cites this paper
• MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.

  2008cites this paper
• Aerodynamical, Immunological and Pharmacological Properties of the Anticancer Antibody Cetuximab Following Nebulization

  2008cites this paper
• Injectable chitosan hydrogels for localised cancer therapy.

  2008cites this paper
• Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.

  2008cites this paper
• Disease guided optimization of the respiratory delivery of microparticulate formulations.

  2008cites this paper
• Concept and clinical evaluation of carrier-mediated anticancer agents.

  2008cites this paper
• Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.

  2008cites this paper
• Disease guided optimization of the respiratory delivery of microparticulate formulations

  2008cites this paper
• Aerosolized Chemotherapy

  2008cites this paper
• Controlled release of 9-nitro-20(S)-camptothecin from methoxy poly(ethylene glycol)-poly(D,L-lactide) micelles

  2008cites this paper
• Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes.

  2008cites this paper
• Improved biochemical strategies for targeted delivery of taxoids.

  2007cites this paper
• Amphiphilic triblock copolymer poly(p-dioxanone-co-L-lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery

  2007cites this paper
• Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model

  2006influential citation
• Liposome-nanogel structures for future pharmaceutical applications.

  2006cites this paper
• Taiwanese Native Medicinal Plants: Phytopharmacology and Therapeutic Values

  2006cites this paper
• Anti‐cancer effect of celecoxib and aerosolized docetaxel against human non‐small cell lung cancer cell line, A549

  2006cites this paper
• A novel non-toxic camptothecin formulation for cancer chemotherapy.

  2005cites this paper
• A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture.

  2005cites this paper
• Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents

  2005cites this paper
• Alternative administration of camptothecin analogues

  2005cites this paper
• Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice

  2004influential citation
• Targeted liposomal drug delivery in cancer.

  2004cites this paper
• Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies

  2004cites this paper
• Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.

  2004cites this paper
• Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.

  2004cites this paper
• Comparison of Vitamin E Derivatives α-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis

  2004cites this paper
• Vitamin E Analog α-TEA and Celecoxib Alone and Together Reduce Human MDA-MB-435-FL-GFP Breast Cancer Burden and Metastasis in Nude Mice

  2004cites this paper
• Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis

  2004cites this paper
• The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.

  2003cites this paper
• Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.

  2003cites this paper
• Investigation of the effect of a novel vitamin E derivative (alpha-TEA) alone and in combination with a known chemotherapuetic agent in human breast cancer using cell culture and animal models

  2003cites this paper
• Camptothecins and lung cancer: improved delivery systems by aerosol.

  2003cites this paper
• Aerosol therapy for malignancy involving the lungs.

  2003cites this paper
• Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis.

  2003cites this paper
• Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.

  2003cites this paper
• RETRACTED: Polyethyleneimine-based gene therapy by inhalation

  2003cites this paper
• Current status and perspectives in the development of camptothecins.

  2002cites this paper
• 9-NITROCAMPTOTHECIN LIPOSOME AEROSOL: LACK OF SUBACUTE TOXICITY IN DOGS

  2002cites this paper
• Camptothecin Delivery Methods

  2002cites this paper
• Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin

  2002cites this paper
• Inhalation Delivery of Anticancer Agents via HFA-Based Metered Dose Inhaler Using Methotrexate as a Model Drug

  2002cites this paper
• 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.

  2001cites this paper
• Liposomal cancer chemotherapy: current clinical applications and future prospects

  2001cites this paper
• Modulation of camptothecin analogs in the treatment of cancer: a review

  2001cites this paper
• In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.

  2001cites this paper
• Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies

  2001cites this paper
• Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.

  2001cites this paper
• Alternative Administration of Camptothecin Analogues

  2000cites this paper
• Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery.

  2000cites this paper
• 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.

  2000cites this paper
• Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice.

  2000cites this paper
• Literature alerts.

  2000cites this paper
• Evaluation of drug targeting strategies and liposomal trafficking.

  2000cites this paper
• 9‐Nitrocamptothecin Liposome Aerosol Treatment of Human Cancer Subcutaneous Xenografts and Pulmonary Cancer Metastases in Mice

  2000cites this paper
• Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice

  1999cites this paper